Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy

Surgery

Volumn 132, Issue 3, 2002, Pages 495-501

  Heidecke, Claus Dieter ^a,b   Weighardt, Heike ^a,b   Feith, Marcus ^a,b   Fink, Ulrich ^a,b   Zimmermann, Frank ^a,b   Stein, Hubert J ^a,b   Siewert, Jörg Rüdiger ^a,b   Holzmann, Bernhard ^a,b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLUOROURACIL; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; SUPERANTIGEN;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0036747093     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(02)00116-2     Document Type: Article

References (20)

1. Stein HJ, Fink U, Siewert JR. Who benefits from combined modality treatment of esophageal carcinoma? Dis Esoph 1994;7:156-61.
2. Stein HJ, Sendler A, Fink U, Siewert JR. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 2000;80:659-82.
3. Nakayama Y, Makino S, Fukuda Y, Min KY, Ikemoto T, Shimizu A, Ohsawa N. Varied effects of thoracic irradiation on peripheral lymphocyte subsets in lung cancer patients. Intern Med 1995;34:959-65.
4. Tisch M, Heimlich F, Daniel V, et al. Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg 1998;119:412-7.
5. Vuckovic-Dekic L, Susnjar S, Stanojevic-Bakic N, Radosavljevic D. Radio- and chemotherapy variably affect the general immunocompetence of lung cancer patients. Panminerva Med 1999;41:129-33.
6. Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman J, Pecorelli S, Cannon M, Parham GP. Effects of concurrent cis-platinum administration during radiotherapy versus radiotherapy alone on the immune function of patients with cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 2000;48:997-1006.
7. Hensler T, Hecker H, Heeg K, et al. Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 1997;65:2283-91.
8. Faist E, Schinkel C, Zimmer S, Kremer JP, von Donnersmarck GH, Schildberg FW. Inadequate interleukin-2 synthesis and interleukin-2 messenger expression following thermal and mechanical trauma in humans is caused by defective transmembrane signaling. J Trauma 1993;34:846-53.
9. Horgan AF, Mendez MV, O'Riordain DS, et al. Altered gene transcription after burn injury results in depressed T lymphocyte activation. Ann Surg 1994;220:342-51.
10. Heidecke CD, Hensler T, Weighardt H, et al. Selective defects of T lymphocyte function in patients with lethal intra-abdominal infection. Am J Surg 1999;178:288-92.
11. Fink U, Stein HJ, Wilke H. Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995;19:198-204.
12. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997;337:161-7.
13. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative short-term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Cancer 1995;75:2269-75.
14. Eguchi R, Ide H, Nakamura T, Chu KM, Wong J. Analysis of postoperative complications after esophagectomy for esophageal cancer in patients receiving neoadjuvant therapy. Jpn J Thorac Cardiovasc Surg 1999;47:552-8.
15. Law S, Fok M, Chow S, Chu KM, Wong J. Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 1997;114:210-7.
16. Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-84.
17. Sugimachi K, Kitamura M, Maekawa S, Matsufuji H, Kai H, Okudarja Y. Two-stage operation for poor-risk patients with carcinoma of the esophagus. J Surg Oncol 1987;36:105-9.
18. Saito T, Shimoda K, Shigemitsu Y, Kinoshita T, Miyahara M, Kobayashi M. Extensive lymphadenectomy for thoracic esophageal carcinoma: a 2-stage operation for high-risk patients. Surg Today 1994;24:610-5.
19. DiPierro FV, Rice TW, DeCamp MM, Rybicki LA, Blackstone EH. Esophagectomy and staged reconstruction. Eur J Cardiothorac Surg 2000;17:702-9.
20. Stein HJ, Bartels H, Siewert JR. Esophageal carcinoma: two-stage operation for preventing mediastinitis in high risk patients. Chirung 2001;72:831-6.